Haarlem, Netherlands

Jan Theunis Poolman

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 10.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Haalem, NL (2022 - 2024)
  • Vogelenzang, NL (2024)

Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Jan Theunis Poolman: A Pioneer in Bioconjugate Vaccines

Introduction: Jan Theunis Poolman is a prominent inventor based in Haarlem, Netherlands, who has made significant contributions to the field of biotechnology. With a total of five patents to his name, Poolman has focused on creating innovative solutions for immunization against extra-intestinal pathogenic E. coli (ExPEC), paving the way for advancements in vaccine development.

Latest Patents: His latest patents include innovative methods of producing bioconjugates of O-antigen polysaccharides. These methods involve the use of recombinant host cells that encode specific oligosaccharyl transferase enzymes, such as the PglB oligosaccharyl transferase, to produce bioconjugates aimed at improving vaccination strategies. Another noteworthy patent outlines multivalent vaccine compositions designed to induce an immune response against ExPEC, utilizing conjugates of polysaccharide antigen O75 covalently linked to carrier proteins for the prevention of invasive ExPEC diseases.

Career Highlights: Poolman has worked with leading pharmaceutical companies, including Janssen Pharmaceuticals, Inc. and GlaxoSmithKline Biologicals SA. His experience in these organizations has allowed him to engage in cutting-edge research and development, significantly enriching his expertise in bioconjugate technology.

Collaborations: Throughout his career, he has collaborated with notable professionals such as Darren Robert Abbanat and Patricia Ibarra Yon. These partnerships have fostered innovative ideas and strategies, further advancing the development of effective vaccines against pathogenic threats.

Conclusion: Jan Theunis Poolman's contributions to the field of biotechnology reflect his commitment to improving public health through innovative vaccination strategies. His work on bioconjugates and vaccine compositions offers promising avenues for protecting against infectious diseases, showcasing the vital role of inventors in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…